You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DDR pathway gene expression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)

Active, not recruiting
  • Prostate Cancer Aggressiveness
  • Prostate Carcinoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Obesity, Prediabetes Trial in La Jolla (Mirabegron)

Not yet recruiting
  • Obesity, Prediabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Preterm Birth, Mother-Infant Interaction, Infant Development Trial in Cologne (skin-to-skin contact)

Recruiting
  • Preterm Birth
  • +2 more
  • skin-to-skin contact
  • Cologne, Northrhine-westfalia, Germany
    University hospital of Cologne, Department of Neonatology
Aug 4, 2023

d to Reveal Heterogeneity of Secondary Hyperparathyroidism

Not yet recruiting
  • Secondary Hyperparathyroidism
  • Single-cell sequencing
  • (no location specified)
Nov 12, 2023

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

Completed
  • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
  • Avelumab Phase 1b
  • +3 more
  • Fayetteville, Arkansas
  • +57 more
Jan 18, 2023

Sepsis Trial

Not yet recruiting
  • Sepsis
    • (no location specified)
    Oct 6, 2023

    Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

    Recruiting
    • Malignant Solid Neoplasms
    • Nilotinib (400 mg BID)
    • +6 more
    • Bordeaux, France
    • +6 more
    Dec 15, 2022

    ACE2 Gender Differences in Stroke With COVID-19

    Recruiting
    • Neurologic Manifestations
    • Robotic assisted intervention
    • +2 more
    • Rome, Italy
      Fondazione Don Carlo Gnocchi
    Nov 17, 2021

    Klotho _ LRP-6 _ Gastric Adenocarcinoma

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Prognostic study
    • (no location specified)
    Jan 29, 2023

    Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

    Not yet recruiting
    • Warts
    • Detection of expression of SOCS3 gene
    • +2 more
    • (no location specified)
    Mar 12, 2023

    IBD Trial in Toulouse (Endoscopic biopsies)

    Recruiting
    • Inflammatory Bowel Diseases
    • Endoscopic biopsies
    • Toulouse, France
      Hopital des Enfants
    Aug 17, 2022

    Depression Mild, Depression Moderate Trial in San Francisco (Yoga practice, Education)

    Not yet recruiting
    • Depression Mild
    • Depression Moderate
    • Yoga practice
    • Education
    • San Francisco, California
      University of California San Francisco
    Oct 13, 2023

    Innate Immunity in Allergic Asthma

    Recruiting
    • Asthma
      • Orlando, Florida
        University of Central Florida
      Sep 28, 2023

      Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

      Recruiting
      • Metastatic Malignant Solid Neoplasm
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 16, 2021

      Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

      Recruiting
      • Biliary Tract Cancer
      • DNA Damage Repair Deficiency
      • Seoul, Korea, Republic of
        Asan Medical Center
      Apr 8, 2022

      Genetics of Heart Failure Clinical Stages

      Completed
      • Heart Failure
      • quantitative polymerase chain reaction(QPCR) for seven genes
      • Cardiac biopsy
      • Asyūţ, Egypt
        cardiology hospital (Asyut University, Asyut, Egypt)
      Aug 17, 2022

      Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

      Recruiting
      • Prostate Cancer
      • talazoparib plus enzalutamide
      • Placebo plus enzalutamide
      • Birmingham, Alabama
      • +306 more
      Jan 18, 2023

      Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • RP-3500 in combination with Olaparib
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Sep 23, 2022

      IL13 Signaling in Allergic Asthma

      Not yet recruiting
      • Asthma, Allergic
      • +2 more
        • Durham, North Carolina
          Duke Asthma Allergy and Airway Center
        Jul 26, 2022

        Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

        Active, not recruiting
        • Diabetic Nephropathy
        • Grouping based on previous laboratory results, no intervention.
        • Jinan, Shandong, China
          Qianfoshan Hospital
        Oct 24, 2023

        Neuroblastoma Precision Trial

        Active, not recruiting
        • Neuroblastoma
        • Gene panel sequencing of tumor specimens
        • Los Angeles, California
        • +10 more
        Feb 16, 2022